Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Ophthalmologic Surgery More
The antibody detects a protein of Candida famata and is useful for detection of candidiasis and retinopathies in samples from blood, urine, aqueous humour, vitreous humour, and cerebral spinal fluid without interference from other species of Candida More
Balanced salt solution (BSS) audible alarm device More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
King’s researchers and Guy’s & St Thomas’s NHS collaborators have discovered biomarkers which are diagnostic for early stage diabetic retinopathy (DR) and are also a measure of disease progression. More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
The Glaucoma Implant is a new shunt that eliminates the complications created by devices currently in use and it may eliminate the need for repeat surgeries. It is small in size, easy to implant and thus causes less discomfort for the patient and results. More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.innovaro.com
Wrigley's 5 Gum Case Study: remaining competitive in the gum market through a multi-sensory offering
Aug 2009 - 10 pages - $295
Nov 2010 - 146 pages - $3,500
Jun 2006 - 422 pages - $2,495
Apr 2010 - 510 pages - $2,695
Oct 2011 - 64 pages - $500
Apr 2011 - 951 pages - $4,995
Aug 2010 - 148 pages - $2,500
Aug 2010 - 165 pages - $2,500
Aug 2010 - 153 pages - $2,500
Aug 2010 - 166 pages - $2,500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Cataract
- Chlamydia trachomatis
- Conjunctivitis
- Corneal erosion
- Corneal ulcer
- Diabetic retinopathy
- Dry eyes
- Glaucoma
- Hyperopia
- Macular degeneration
- Ophthalmic disorder (other)
- Retinopathy
- Sight disorders
- Uveitis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us